421 related articles for article (PubMed ID: 19474467)
1. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.
Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA
Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467
[TBL] [Abstract][Full Text] [Related]
2. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
[TBL] [Abstract][Full Text] [Related]
4. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
[TBL] [Abstract][Full Text] [Related]
5. Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.
Côté HC; Raboud J; Bitnun A; Alimenti A; Money DM; Maan E; Costei A; Gadawski I; Diong C; Read S; Shen S; Harrigan PR; Burdge DR; King SM; Forbes JC
J Infect Dis; 2008 Sep; 198(6):851-9. PubMed ID: 18684095
[TBL] [Abstract][Full Text] [Related]
6. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
[TBL] [Abstract][Full Text] [Related]
7. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
[TBL] [Abstract][Full Text] [Related]
8. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.
Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS
Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women.
López S; Coll O; Durban M; Hernàndez S; Vidal R; Suy A; Morén C; Casademont J; Cardellach F; Mataró D; Miró O; Garrabou G
Antivir Ther; 2008; 13(6):833-8. PubMed ID: 18839784
[TBL] [Abstract][Full Text] [Related]
10. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
[TBL] [Abstract][Full Text] [Related]
11. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
Martin F; Taylor GP
J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
[TBL] [Abstract][Full Text] [Related]
13. Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells.
Walker UA; Venhoff N; Koch EC; Olschewski M; Schneider J; Setzer B
Antivir Ther; 2003 Oct; 8(5):463-70. PubMed ID: 14640394
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients.
Einsiedel L; Cherry CL; Sheeran FL; Friedhuber A; Wesselingh SL; Pepe S
Mitochondrion; 2010 Aug; 10(5):534-9. PubMed ID: 20685321
[TBL] [Abstract][Full Text] [Related]
15. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
[TBL] [Abstract][Full Text] [Related]
16. HIV and mitochondrial toxicity in children.
Foster C; Lyall H
J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978
[TBL] [Abstract][Full Text] [Related]
17. Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?
de Mendoza C; Sanchez-Conde M; Ribera E; Domingo P; Soriano V
AIDS Rev; 2004; 6(3):169-80. PubMed ID: 15595434
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
[TBL] [Abstract][Full Text] [Related]
19. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
[TBL] [Abstract][Full Text] [Related]
20. Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery.
Nasi M; Pinti M; Chiesa E; Fiore S; Manzini S; Del Giovane C; D'Amico R; Palai N; Campatelli C; Sabbatini F; Roccio M; Tibaldi C; Masuelli G; Mussini C; Ferrazzi E; d'Arminio Monforte A; Cossarizza A;
Antivir Ther; 2011; 16(3):365-72. PubMed ID: 21555819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]